In the December 14, 2009, issue, McCullough et al1 presented a systematic review of randomized trials that used coronary artery calcification (CAC) progression as the primary end point. Despite the noninclusion of 2 eligible randomized placebo-controlled trials,2,3 we agree with their assertion that CAC progression has not been consistently reduced in any therapeutic randomized trial to date.